C - Chemistry – Metallurgy – 07 – K
Patent
C - Chemistry, Metallurgy
07
K
C07K 16/24 (2006.01) A61K 39/395 (2006.01) A61P 11/06 (2006.01) C12N 5/10 (2006.01) C12N 15/13 (2006.01)
Patent
CA 2635972
The present invention concerns immunoglobulins, particularly antibodies which specifically bind human lnterleukin 13 (hlL-13). Antibodies of the invention may be used in the treatment of a variety of diseases or disorders responsive to modulation of the interaction between hlL-13 and the human IL-13 receptor. Such diseases include severe asthma, atopic dermatitis, COPD and various fibrotic diseases. Pharmaceutical compositions comprising said antibodies and methods of manufacture are also disclosed.
La présente invention concerne des immunoglobulines, en particulier des anticorps qui se lient spécifiquement à l'interleukine 13 humaine (hIL-13). Les anticorps de l'invention peuvent être utilisés dans le traitement de diverses maladies ou troubles qui réagissent à la modulation de l'interaction entre la hIL-13 et le récepteur de l'IL-13 humaine. Ces maladies comprennent l'asthme grave, la dermatite atopique, la BPCO ainsi que diverses maladies fibrotiques. La présente invention concerne également des compositions pharmaceutiques comprenant lesdits anticorps, ainsi que des procédés de fabrication.
Ashman Claire
Cassidy Martin John
Clarkson Jane Elizabeth
Ellis Jonathan Henry
Wattam Trevor Anthony Kenneth
Glaxo Group Limited
Ogilvy Renault Llp/s.e.n.c.r.l.,s.r.l.
LandOfFree
Chimeric and humanised anti-human il-13 antibodies does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Chimeric and humanised anti-human il-13 antibodies, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Chimeric and humanised anti-human il-13 antibodies will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1616918